Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Indravadan Patel
Randomised, Parallel-Group, Multicentre, Multinational Phase 2 Study Comparing Edoxaban, an Oral Factor Xa Inhibitor, With Warfarin for Stroke Prevention in Patients With Atrial Fibrillation
Thrombosis and Haemostasis
Hematology
Related publications
Suboptimal Anticoagulant Management in Japanese Patients With Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention
Journal of Stroke and Cerebrovascular Diseases
Surgery
Neurology
Cardiovascular Medicine
Rehabilitation
Cardiology
Cost-Effectiveness of Rivaroxaban for the Prevention of Stroke in Patients With Non-Valvular Atrial Fibrillation – A Multinational Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Prevention of Cardiovascular Outcomes in Diabetic Patients With Atrial Fibrillation: Direct Oral Anticoagulants or Warfarin?
Clinical pharmacology and therapy
Cost-Effectiveness of Apixaban Compared With Aspirin for Stroke Prevention in Atrial Fibrillation Among Patients Unsuitable for Warfarin
Circulation. Cardiovascular quality and outcomes
Medicine
Cardiovascular Medicine
Cardiology
Cost-Effectiveness Analysis of Apixaban Against Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation in Japan
Clinical Therapeutics
Pharmacology
Pcv75 - An Updated Cost-Effectiveness Pairwise Analysis of Apixaban and Warfarin for Stroke Prevention in Patients With Non- Valvular Atrial Fibrillation in France
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Transient Ischemic Attacks in Patients With Atrial Fibrillation: Implications for Secondary Prevention: The European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III Trial
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Pcv84 - Cost-Effectiveness Analysis of Apixaban Versus Edoxaban for Stroke Prevention in Non-Valvular Atrial Fibrillation Spanish Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness of New Oral Anticoagulants Compared With Warfarin in Preventing Stroke and Other Cardiovascular Events in Patients With Atrial Fibrillation
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
